查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298660

药物警戒和药物安全软件市场：2023-2028年全球行业趋势、份额、规模、增长、机会及预测

Pharmacovigilance and Drug Safety Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

全球药物警戒和药物安全软件市场规模在2022年达到1.899亿美元。展望未来，IMARC集团预计到2028年，该市场规模将达到2.833亿美元，2023-2028年期间的年复合增长率（CAGR）为6.51%。

药物警戒和药品安全软件用于检测、评估、了解和预防与药品、医疗器械和医药产品相关的不良反应。全球的医疗保健公司都在使用该软件，以确保全球监管合规性，更快地做出科学的安全决策，整合安全和风险管理，并降低药物警戒的成本。如今，服务提供商正在提供灵活、创新和可扩展的变体，以满足医疗保健公司独特的业务和产品安全要求。

药物警戒和药品安全软件市场趋势：

药物警戒和药物安全监测是医药产品开发商、许可证持有者和临床研究者的强制性要求。然而，药物警戒和药物安全监测是一个时间密集、成本高昂的过程，这也是促使采用药物警戒和药物安全软件来维护安全数据、降低成本并提供最佳监测和报告工作流程的关键因素之一。此外，许多国家的卫生机构正在实施严格的公共卫生法律，这也鼓励制药和生物技术公司采用高效的药物警戒和药物安全软件。此外，由于药物不良反应（ADR）发生率的上升，全球对安全药物和药品的需求也在不断攀升，这也促进了市场的增长。除此之外，由于临床试验的快速数字化，药物警戒和药物安全软件的采用率也在上升，以确保在不破坏传统信号检测、验证和管理工作流程的情况下实施新方法。此外，知名厂商正在实施自动化，采用先进技术，并利用分析结果提高药物警戒和药物安全软件的合规性和产品安全性。预计这将为市场带来积极的前景。

目录

第一章：前言

第二章：范围和方法

  • 研究目标
  • 利益相关者
  • 数据来源
    • 第一手资料
    • 二手资料
  • 市场评估
    • 自下而上法
    • 自上而下法
  • 预测方法

第三章：执行摘要

第四章 : 简介

  • 概述
  • 主要行业趋势

第5章：全球药物警戒和药物安全软件市场

  • 市场概述
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按功能分類的市场细分

  • 不良事件报告软件
    • 市场趋势
    • 市场预测
  • 药品安全审计软件
    • 市场趋势
    • 市场预测
  • 问题跟踪软件
    • 市场趋势
    • 市场预测
  • 全集成软件
    • 市场趋势
    • 市场预测

第七章 ：按交付模式分類的市场细分

  • 企业内部
    • 市场趋势
    • 市场预测
  • 云计算
    • 市场趋势
    • 市场预测

第八章：按最终用户分類的市场细分

  • 制药和生物技术公司
    • 市场趋势
    • 市场预测
  • 合同研究组织
    • 市场趋势
    • 市场预测
  • 业务流程外包公司
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本市场
      • 市场趋势
      • 市场预测
    • 印度市场
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他市场
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利市场
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他市场
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西市场
      • 市场趋势
      • 市场预测
    • 墨西哥市场
      • 市场趋势
      • 市场预测
    • 其他市场
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 各国市场细分
    • 市场预测

第10章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特五力分析

  • 五力分析概述
  • 买方议价能力
  • 供应商议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要竞争者
  • 主要竞争者简介
    • Ab Cube
    • Anju Software Inc.
    • ArisGlobal LLC
    • Cognizant
    • Ennov Solutions Inc.
    • Extedo GmbH
    • Max Application
    • Oracle Corporation
    • Sarjen Systems Pvt Ltd
    • Sparta Systems Inc. (Honeywell International Inc.)
    • Tata Consultancy Services Limited
    • United BioSource LLC
    • Wipro Limited
Product Code: SR112023A5030

The global pharmacovigilance and drug safety software market size reached US$ 189.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 283.3 Million by 2028, exhibiting a growth rate (CAGR) of 6.51% during 2023-2028.

Pharmacovigilance and drug safety software is used to detect, assess, understand, and prevent adverse effects related to medicines, medical devices, and pharmaceutical products. It is utilized by health firms worldwide to ensure global regulatory compliance, make faster science-based safety decisions, integrate safety and risk management, and lower the cost of pharmacovigilance. Nowadays, service providers are offering flexible, innovative, and scalable variants to meet the unique business and product safety requirements of health firms.

Pharmacovigilance and Drug Safety Software Market Trends:

Pharmacovigilance and drug safety monitoring are mandatory requirements for medicinal product developers, license holders, and clinical investigators. However, they can be time-intensive and costly processes, which represents one of the key factors catalyzing the adoption of pharmacovigilance and drug safety software to maintain safety data, minimize costs, and deliver best-practice monitoring and reporting workflows. In addition to this, health agencies of numerous countries are implementing stringent laws regarding public health, which is encouraging pharmaceutical and biotechnology companies to adopt efficient software for pharmacovigilance and drug safety. Moreover, the escalating demand for safe drugs and medicines around the world on account of the increasing incidences of adverse drug reaction (ADR) is contributing to the market growth. Apart from this, due to the rapid digitization of clinical trials, there is a rise in the adoption of pharmacovigilance and drug safety software to ensure the implementation of novel methods without disrupting traditional signal detection, validation, and management workflow. Furthermore, prominent vendors are implementing automation, adopting advanced technologies, and leveraging insights from analytics that improve compliance and product safety in pharmacovigilance and drug safety software. This is anticipated to provide a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance and drug safety software market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on functionality, delivery mode and end user.

Breakup by Functionality:

Adverse Event Reporting Software

Drug Safety Audits Software

Issue Tracking Software

Fully Integrated Software

Breakup by Delivery Mode:

On-premises

Cloud-based

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Business Process Outsourcing Firms

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Cube, Anju Software Inc., ArisGlobal LLC, Cognizant, Ennov Solutions Inc., Extedo GmbH, Max Application, Oracle Corporation, Sarjen Systems Pvt Ltd, Sparta Systems Inc. (Honeywell International Inc.), Tata Consultancy Services Limited, United BioSource LLC and Wipro Limited.

Key Questions Answered in This Report

1. What was the size of the global pharmacovigilance and drug safety software market in 2022?

2. What is the expected growth rate of the global pharmacovigilance and drug safety software market during 2023-2028?

3. What has been the impact of COVID-19 on the global pharmacovigilance and drug safety software market?

4. What are the key factors driving the global pharmacovigilance and drug safety software market?

5. What is the breakup of the global pharmacovigilance and drug safety software market based on the functionality?

6. What is the breakup of the global pharmacovigilance and drug safety software market based on the delivery mode?

7. What is the breakup of the global pharmacovigilance and drug safety software market based on the end user?

8. What are the key regions in the global pharmacovigilance and drug safety software market?

9. Who are the key players/companies in the global pharmacovigilance and drug safety software market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmacovigilance and Drug Safety Software Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Functionality

  • 6.1 Adverse Event Reporting Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Safety Audits Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Issue Tracking Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Fully Integrated Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Delivery Mode

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Business Process Outsourcing Firms
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ab Cube
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Anju Software Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 ArisGlobal LLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cognizant
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Ennov Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Extedo GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Max Application
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Oracle Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sarjen Systems Pvt Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sparta Systems Inc. (Honeywell International Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Tata Consultancy Services Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 United BioSource LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wipro Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmacovigilance and Drug Safety Software Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Functionality (in %), 2022
  • Figure 5: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Delivery Mode (in %), 2022
  • Figure 6: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pharmacovigilance and Drug Safety Software (Adverse Event Reporting Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmacovigilance and Drug Safety Software (Adverse Event Reporting Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmacovigilance and Drug Safety Software (Drug Safety Audits Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmacovigilance and Drug Safety Software (Drug Safety Audits Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmacovigilance and Drug Safety Software (Issue Tracking Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmacovigilance and Drug Safety Software (Issue Tracking Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmacovigilance and Drug Safety Software (Fully Integrated Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmacovigilance and Drug Safety Software (Fully Integrated Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmacovigilance and Drug Safety Software (On-premises) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmacovigilance and Drug Safety Software (On-premises) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmacovigilance and Drug Safety Software (Cloud-based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmacovigilance and Drug Safety Software (Cloud-based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmacovigilance and Drug Safety Software (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmacovigilance and Drug Safety Software (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmacovigilance and Drug Safety Software (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmacovigilance and Drug Safety Software (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmacovigilance and Drug Safety Software (Business Process Outsourcing Firms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmacovigilance and Drug Safety Software (Business Process Outsourcing Firms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmacovigilance and Drug Safety Software (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmacovigilance and Drug Safety Software (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Pharmacovigilance and Drug Safety Software Industry: SWOT Analysis
  • Figure 78: Global: Pharmacovigilance and Drug Safety Software Industry: Value Chain Analysis
  • Figure 79: Global: Pharmacovigilance and Drug Safety Software Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmacovigilance and Drug Safety Software Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Functionality (in Million US$), 2023-2028
  • Table 3: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Delivery Mode (in Million US$), 2023-2028
  • Table 4: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pharmacovigilance and Drug Safety Software Market: Competitive Structure
  • Table 7: Global: Pharmacovigilance and Drug Safety Software Market: Key Players